MedTech Dive November 29, 2023
Nick Paul Taylor

The actions include using the Defense Production Act to enable investment in U.S. manufacturing of essential medicines and medical countermeasures, such as diagnostics.

Dive Brief:

  • President Joe Biden unveiled a list of new actions Monday to strengthen U.S. supply chains, including using the Defense Production Act (DPA) to enable investment in the manufacturing of medicines and medical countermeasures, such as diagnostic tests and personal protective equipment.
  • Biden, who took office as the COVID-19 pandemic was disrupting the flow of goods, framed the actions as a way to strengthen supply chains, enable reliable deliveries for businesses and create U.S. jobs. Along with the announcement, Biden held the inaugural meeting of a new cabinet-level White House council on logistics resilience
  • Medtech...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Biotechnology, Congress / White House, Govt Agencies, HHS, Medical Devices, Pharma, Pharma / Biotech, Supply Chain, Technology
Where Medicaid cuts stand
Will Congress’s new AI plan survive Trump?
Black Book Finds Tariff Pressures Driving Reshoring of U.S. Healthcare Manufacturing
Trump administration announces new tariff plan
ACA enrollment increase driven by growth in states won by Trump: KFF

Share This Article